57O A phase I/II multicenter, first-in-human study of DB-1311/BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors.
Saved in:
| Title: | 57O A phase I/II multicenter, first-in-human study of DB-1311/BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors. |
|---|---|
| Authors: | Cheng, Y.1 (AUTHOR), Wu, L.2 (AUTHOR), Parsonson, A.3 (AUTHOR), Amin, H.4 (AUTHOR), Shi, J.5 (AUTHOR), Lemech, C.6 (AUTHOR), Sun, Y.7 (AUTHOR), Schmidt, A.8 (AUTHOR), Lv, D.9 (AUTHOR), Li, M.10 (AUTHOR), Zheng, T.11 (AUTHOR), Chaudhry, A.12 (AUTHOR), Gandhi, C.4 (AUTHOR), Wang, Q.13 (AUTHOR), Motino, D.A. Montoya14 (AUTHOR), Abed, A.15 (AUTHOR), Tibes, R.16 (AUTHOR), Lu, X.17 (AUTHOR), Gu, V.17 (AUTHOR), Lisberg, A.E.18 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 4, Vol. 35, pS1426-S1426. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.10.078 |
